Helmholtz Gemeinschaft


Recent developments in the treatment of obesity-related hypertension

Item Type:Review
Title:Recent developments in the treatment of obesity-related hypertension
Creators Name:Pischon, T. and Sharma, A.M.
Abstract:Purpose of review: Obesity is a major public health issue, and hypertension is one of the most common associated co-morbidities. Here, recent developments in the treatment of obesity-related hypertension, published during the past year, are reviewed. Recent findings: Several recent studies have examined the effect of dietary and lifestyle changes on hypertension. These studies uniformly confirm that weight reduction together with salt restriction and increased physical exercise can lower blood pressure. Several studies have shown that pharmacologically induced weight reduction with orlistat or sibutramine can likewise be beneficial in the management of obese hypertensive patients. The role of surgery in obesity remains to be defined. Summary: Both non-pharmacologically and pharmcologically induced weight loss can lower blood pressure in obese hypertensive patients. The effects of weight loss and pharmacological management on morbidity and mortality in obese hypertensive patients remains to be addressed in prospective trials.
Keywords:Hypertension, Obesity, Therapy, Treatment
Source:Current Opinion in Nephrology and Hypertension
Publisher:Lippincott Williams & Wilkins
Page Range:497-502
Date:September 2002
Official Publication:https://doi.org/10.1097/00041552-200209000-00004
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library